ESC 365 - Atrial fibrillation after closure of persistent foramen ovale in the REDUCE clinical trial.

ESC Premium Access

Atrial fibrillation after closure of persistent foramen ovale in the REDUCE clinical trial.

Session: Poster Session 7 - Stroke - Heart: clinical interactions

Topic: Patent Foramen Ovale and Patent Foramen Ovale (PFO) Closure

Speaker: Associate Professor A. Andersen (Aarhus, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Associate Professor Asger Andersen

Aarhus University Hospital, Aarhus (Denmark)

2 presentations

0 follower

9 more presentations in this session

The left atrial appendage morphology correlates with stroke risk in patients with sinus rhythm

Speaker: Doctor N. Libiszewska (Krakow, PL)

Use of routine E/A ratio echocardiographic following cerebral ischemia is associated with paroxysmal atrial fibrillation

Speaker: Doctor C. Bergerot (Lyon, FR)

High proportion of ischemic strokes may be due to low adherence to oral anticoagulation guidelines among patients with atrial fibrillation and stroke risk factors

Speaker: Professor G. Boriani (Modena, IT)

Impact of admission plasma D-dimer level on short-term risk of ischemic stroke in hospitalized patients with acute heart failure

Speaker: Doctor Y. Hamatani (Kyoto, JP)

Endothelial dysfunction as a potential link between interatrial septal abnormalities and methylene tetrahydrofolate reductase (MTHFR)-inherited thrombophilia. A preliminary study on cryptogenic stroke

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Access the full session

Poster Session 7 - Stroke - Heart: clinical interactions

Speakers: Associate Professor A. Andersen, Doctor N. Libiszewska, Doctor C. Bergerot, Professor G. Boriani, Doctor Y. Hamatani...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources